<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Thu, 23 Apr 2026 08:38:36 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/intalfa3miuinjection/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Immunotherapy Approaches for Follicular Lymphoma]]></title><description><![CDATA[Follicular lymphoma, a type of non-Hodgkin lymphoma, is characterized by slow-growing tumors in the lymphatic system. While the traditional treatment paradigm has typically centered around chemotherapy]]></description><link>http://direct.ecency.com/mrmed/@mrmed/immunotherapy-approaches-for-follicular-lymphoma</link><guid isPermaLink="true">http://direct.ecency.com/mrmed/@mrmed/immunotherapy-approaches-for-follicular-lymphoma</guid><category><![CDATA[mrmed]]></category><dc:creator><![CDATA[mrmed]]></dc:creator><pubDate>Wed, 05 Jun 2024 04:41:15 GMT</pubDate></item><item><title><![CDATA[Advancements in Immunotherapy for Malignant Melanoma]]></title><description><![CDATA[Immunotherapy is a breakthrough in cancer treatment, a paradigm shift away from conventional therapies to utilize the immune system of the body and combat malignant melanoma. This method involves strengthening]]></description><link>http://direct.ecency.com/mrmed/@mrmed/advancements-in-immunotherapy-for-malignant</link><guid isPermaLink="true">http://direct.ecency.com/mrmed/@mrmed/advancements-in-immunotherapy-for-malignant</guid><category><![CDATA[mrmed]]></category><dc:creator><![CDATA[mrmed]]></dc:creator><pubDate>Wed, 10 Apr 2024 10:49:12 GMT</pubDate></item></channel></rss>